Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen to reduce blood product transfusion in pediatric craniosynostosis surgery
2011-002287-24Phase 3Terminated
- Sponsor
- Erasmus MC
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Craniosynostosis and Acute major hemorrhage comparing Fibrinogen arm with Placebo arm (2 arms). Primary endpoint: Volume of transfused blood products. Started Dec 2011; status: terminated.
02
Drugs
Fibrinogen human
03
Conditions
CraniosynostosisAcute major hemorrhage
Beyond the preview
Go deeper on 2011-002287-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002287-24.